ResMed Inc. (VIE:RMD)

Market Cap	27.24B -5.1%
Revenue (ttm)	4.60B +9.6%
Net Income	1.27B +19.0%
EPS	8.61 +19.4%
Shares Out	n/a
PE Ratio	21.52
Forward PE	18.80
Dividend	2.00 (1.08%)
Ex-Dividend Date	Feb 12, 2026

Volume	n/a
Average Volume	1
Open	188.05
Previous Close	186.60
Day's Range	185.95 - 188.05
52-Week Range	185.95 - 251.50
Beta	n/a
RSI	29.47
Earnings Date	Apr 30, 2026

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1989
• Employees: 10,600
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: RMD

Financial Performance

In fiscal year 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in USD